reduce basal insulin dose when starting glp-1 receptor agonist Initiation and Titration of in Primary Care: Barriers and Practical Solutions MASTERCLASS 1 : GLP-1 RECEPTOR

Data on bone health in the context of calorie restriction and bariatric surgery were also summarized

Objective To determine whether the use of glucagon-like peptide-1 (GLP-1) receptor agonists is associated with an increased risk of suicidal ideation, self-harm, and suicide among patients with type 2 diabetes compared with the use of dipeptidyl peptidase-4 (DPP-4) inhibitors or sodium-glucose cotransporter-2 (SGLT-2) inhibitors

Saffron patented Safr'Inside SafrInside is a patented saffron extract, standardized in crocins and safranal, that supports emotional balance by promoting a positive mood

Disclaimer: This article is for informational purposes only and is not medical advice